University of Cambridge > > Computational and Systems Biology > To be confirmed

To be confirmed

Add to your list(s) Download to your calendar using vCal

  • UserDaniel Crowther
  • ClockWednesday 15 February 2006, 14:00-15:00
  • HouseMR5, DAMTP.

If you have a question about this talk, please contact Stephen Eglen.

GlaxoSmithKline is one of the worlds leading pharmaceutical companies. In this talk I will aim to introduce the drug development process and highlight some of the ways in which bioinformatics is applied to the drug development process in GSK . The talk will focus on several key areas of impact, starting with target identification and validation including the application of structural analysis to protein engineering, describe the role of bioinformatics in handing human variation and finishing with at role bioinformatics plays in the discovery and application of biomarkers.

This talk is part of the Computational and Systems Biology series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2024, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity